Cargando…
Noninvasive proteomic biomarkers for alcohol-related liver disease
Alcohol-related liver disease (ALD) is a major cause of liver-related death worldwide, yet understanding of the three key pathological features of the disease—fibrosis, inflammation and steatosis—remains incomplete. Here, we present a paired liver–plasma proteomics approach to infer molecular pathop...
Autores principales: | Niu, Lili, Thiele, Maja, Geyer, Philipp E., Rasmussen, Ditlev Nytoft, Webel, Henry Emanuel, Santos, Alberto, Gupta, Rajat, Meier, Florian, Strauss, Maximilian, Kjaergaard, Maria, Lindvig, Katrine, Jacobsen, Suganya, Rasmussen, Simon, Hansen, Torben, Krag, Aleksander, Mann, Matthias |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205783/ https://www.ncbi.nlm.nih.gov/pubmed/35654907 http://dx.doi.org/10.1038/s41591-022-01850-y |
Ejemplares similares
-
Prognostic performance of 7 biomarkers compared to liver biopsy in early alcohol-related liver disease
por: Rasmussen, Ditlev Nytoft, et al.
Publicado: (2021) -
Serum keratin‐18 detects hepatic inflammation and predicts progression in compensated alcohol‐associated liver disease
por: Thorhauge, Katrine Holtz, et al.
Publicado: (2022) -
Rifaximin-α for liver fibrosis in patients with alcohol-related liver disease (GALA-RIF): a randomised, double-blind, placebo-controlled, phase 2 trial
por: Israelsen, Mads, et al.
Publicado: (2023) -
Hepatorenal Index by B‐Mode Ratio Versus Imaging and Fatty Liver Index to Diagnose Steatosis in Alcohol‐Related and Nonalcoholic Fatty Liver Disease
por: Kjaergaard, Maria, et al.
Publicado: (2022) -
Alcoholic liver disease: A registry view on comorbidities and disease prediction
por: Grissa, Dhouha, et al.
Publicado: (2020)